Herbst Group »

Esperion Therapeutics shares owned by Herbst Group

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Herbst Group from 13F filings

Historical chart of Herbst Group investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Herbst Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Herbst Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $28k 10k 2.68

More positions owned by Herbst Group

Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Alps Etf Tr Alerian Mlp (AMLP)
Ishares Tr Us Aer Def Etf (ITA)
Apple (AAPL)
Select Sector Spdr Tr Energy (XLE)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Scottsdale Fds Vng Rus2000idx (VTWO)
Oneok (OKE)
Select Sector Spdr Tr Sbi Healthcare (XLV)

View all positions for Herbst Group

Top funds holding Esperion Therapeutics

OrbiMed Advisors
Bellevue Group
Daniel D. Thurber
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Woodline Partners
Millennium Management
D. E. Shaw & Co
Bank of America Corporation
Two Seas Capital
Two Sigma Investments
Meditor
Citadel Advisors
Two Sigma Advisers
Goldman Sachs Group

View all funds holding Esperion Therapeutics